Reported Reactions

Devices › Device types

FDA product code OTN · class 2 · General, Plastic Surgery

Mesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator: medical device reports filed with FDA

38,649 reports carry this product code, 2006–2026; 30 brands with a page.

38,649
reports with this product code
0.2% of all MAUDE reports
343
reports, 12 months to August 2026
435 in the 12 months before
1.6%
classified as malfunction
62.3% across all reports
1%
classified as death, as reported
0.9% across all reports

Product code OTN is FDA's classification for "Mesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator" (general, Plastic Surgery panel), a class 2 device. 38,649 medical device reports carry this product code, 0.2% of the MAUDE database, from November 2006 to August 2026.

343 reports arrived in the 12 months to August 2026, down 21% from 435 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (97.4%), malfunction (1.6%) and death (1%). 30 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
Gynecare Tvt Retropubic System5,29400%0.3%
Gynecare Tvt Obturator System4,33000%0.6%
Tension Free Vaginal Tape3,90400.1%3.9%
Gynecare Mesh Unknown2,97430.1%0%
Gynecare Tvt Oburator System1,57100.1%0%
Tension Free Vaginal Tape Unknown Product1,161240%0.1%
Gynecare Tvt-Aa Abdominal90400%0%
Advantage Fit System897100.1%4.2%
Gynecare Tvt Obturator862150%6.5%
Uretex Support Pp Kit X176600.1%0.7%
Gynecare Tvt Exact Continence System68200%3.5%
Tension Free Vaginal Tape - Obturator Unknown Prod67650%0%
Advantage? System665130%0.3%
Obtryx System66410%0.7%
Gynecare TVT65730%1.3%
Obtape Transobturator Sling58400%0%
Desara57100%0.2%
Tvt Exact Retropubic System547490%6.9%
Gynecare Tvt Device44300%0%
Gynecare Tvt Obturator W Lasr430140%5.3%
Lynx System40990%0.6%
Uretex Support Pp Transobtur2 Kit X137500%0.2%
Gynecare Tvt Abrevo Continence System32400%4.3%
T-Sling31600%0.5%
Ams Monarc Sling System300058%1.3%
Aris Transobturator Kit24000%1.7%
Obtryx? System - Halo22890%7.2%
Align To Urethral Support System21600%0%
Tension Free Vaginal Tape - Exact Unknown Product202280%0%
Ams Sparc Sling System197068%1.5%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Ethicon24,94364.5%
Sofradim Production1,9515%
Ethicon Sarl1,4873.8%
Boston Scientific - Marlborough9952.6%
C R Bard Covington -10182336681.7%
Bard Shannon6131.6%
Coloplast A/S5951.5%
Mentor Worldwide5551.4%
American Medical Systems4421.1%
Caldera Medical4321.1%
C R Bard Covington3851%
American Medical Systems Mn2930.8%
Sofradim Production Sas2320.6%
C R Bard870.2%
Mentor300.1%

Reports by month, five years

0389778Sep 2021: 92Oct 2021: 366Nov 2021: 430Dec 2021: 7782022Jan 2022: 36Feb 2022: 41Mar 2022: 60Apr 2022: 67May 2022: 83Jun 2022: 45Jul 2022: 81Aug 2022: 106Sep 2022: 73Oct 2022: 88Nov 2022: 77Dec 2022: 522023Jan 2023: 48Feb 2023: 42Mar 2023: 76Apr 2023: 45May 2023: 80Jun 2023: 62Jul 2023: 59Aug 2023: 88Sep 2023: 54Oct 2023: 108Nov 2023: 293Dec 2023: 1212024Jan 2024: 154Feb 2024: 167Mar 2024: 162Apr 2024: 45May 2024: 28Jun 2024: 37Jul 2024: 27Aug 2024: 35Sep 2024: 27Oct 2024: 90Nov 2024: 25Dec 2024: 252025Jan 2025: 32Feb 2025: 26Mar 2025: 47Apr 2025: 50May 2025: 49Jun 2025: 25Jul 2025: 22Aug 2025: 17Sep 2025: 22Oct 2025: 93Nov 2025: 55Dec 2025: 252026Jan 2026: 35Feb 2026: 38Mar 2026: 21Apr 2026: 23May 2026: 13Jun 2026: 6Jul 2026: 8Aug 2026: 4

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death1%376
Injury97.4%37,631
Malfunction1.6%607
Other0%9
Not given0.1%26

Who filed

Manufacturer report97.8%37,815
Voluntary report0.7%261
User facility report0%0
Distributor report1.2%479
Not given0.2%94

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Material erosion17,17444.4%
Insufficient device problem information3,2318.4%
Migration or expulsion of device1,9995.2%
Migrationthe device moved from where it was placed1,7874.6%
Other (for use when an appropriate device code cannot be identified)8572.2%
Device operates differently than expectedthe device behaved unexpectedly4441.1%
Extrusion2950.8%
Breakthe device broke1300.3%
Positioning problem870.2%
Patient-device incompatibilitythe device did not suit the patient790.2%
Material integrity problema problem with the device material700.2%
Material protrusion/extrusion570.1%
Detachment of device or device componentpart of the device came off560.1%
Defective devicethe device was defective480.1%
Material twisted/bent470.1%
Material split, cut or torn420.1%
Difficult to advance370.1%
Manufacturing, packaging or shipping problem370.1%
Detachment of device component310.1%
Device appears to trigger rejection280.1%

Questions about mesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator reports

What is product code OTN?

FDA's classification code for "Mesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator", class 2, reviewed by the general, Plastic Surgery panel. Every device report carries the product code of the device involved.

How many reports carry this code?

38,649 reports through August 2026, 343 of them in the latest 12 months.

Which brands appear most often?

Gynecare Tvt Retropubic System (5,294), Gynecare Tvt Obturator System (4,330), Tension Free Vaginal Tape (3,904), Gynecare Mesh Unknown (2,974) and Gynecare Tvt Oburator System (1,571). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.